Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had discussions with his counterpart in the United States on Teplizumab; and (b) what stage Teplizumab is at in the licensing process.
The Medicines and Healthcare products Regulatory Agency is unable to provide the information requested as it is commercially sensitive.